Editas Medicine, Inc.

The current price of EDIT is 5.49 USD — it has decreased by 1.08% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Editas Medicine, Inc. stocks are traded under the ticker EDIT.

Editas Medicine, Inc. is going to release the next earnings report on May 1, 2024. Keep track of upcoming events with our Earnings Calendar.

EDIT stock is 7.47% volatile and has beta coefficient of 2.32. Check out the list of the most volatile stocks — is Editas Medicine, Inc. there?

One year price forecast for Editas Medicine, Inc. has a max estimate of 27.00 USD and a min estimate of 7.00 USD.

EDIT earnings for the last quarter are −0.55 USD per share, whereas the estimation was −0.58 USD resulting in a 4.36% surprise. The estimated earnings for the next quarter are −0.59 USD per share. See more details about Editas Medicine, Inc. earnings.

Editas Medicine, Inc. revenue for the last quarter amounts to ‪5.34 M‬ USD despite the estimated figure of ‪3.70 M‬ USD. In the next quarter revenue is expected to reach ‪3.70 M‬ USD.

Yes, you can track Editas Medicine, Inc. financials in yearly and quarterly reports right on TradingView.

EDIT net income for the last quarter is ‪−18.87 M‬ USD, while the quarter before that showed ‪−45.02 M‬ USD of net income which accounts for 58.08% change. Track more Editas Medicine, Inc. financial stats to get the full picture.

Today Editas Medicine, Inc. has the market capitalization of ‪456.40 M‬, it has decreased by 2.18% over the last week.

No, EDIT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, EDIT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Editas Medicine, Inc. stock right from TradingView charts — choose your broker and connect to your account.

EDIT reached its all-time high on Jan 8, 2021 with the price of 99.95 USD, and its all-time low was 6.08 USD and was reached on Oct 23, 2023.
See other stocks reaching their highest and lowest prices.

As of Apr 20, 2024, the company has 265.00 employees. See our rating of the largest employees — is Editas Medicine, Inc. on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Editas Medicine, Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Editas Medicine, Inc. stock shows the sell signal. See more of Editas Medicine, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

We've gathered analysts' opinions on Editas Medicine, Inc. future price: according to them, EDIT price has a max estimate of 27.00 USD and a min estimate of 7.00 USD. Read a more detailed Editas Medicine, Inc. forecast: see what analysts think of Editas Medicine, Inc. and suggest that you do with its stocks.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Editas Medicine, Inc. EBITDA is ‪−163.12 M‬ USD, and current EBITDA margin is −208.80%. See more stats in Editas Medicine, Inc. financial statements.